Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?

Libido

Key Findings

The identification of Δ9-THC and later on, the discovery of the ECS have opened a potential therapeutic target for sexual dysfunctions, given the partial efficacy of current pharmacological treatment.

Information and Links


Link: Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?

Year: 2017

DOI: 10.1016/j.phrs.2016.11.021


Ratings

(How Ratings Work)

Libido — 3


Likely probability of the efficacy of cannabis for treatment of Libido according to the results found in this study.

Drugs Used

ECS review